
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on January 12, 2026, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 1,000,000 restricted stock units of Cardlytics to its newly appointed Chief Financial Officer, David Evans. The restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted under the Cardlytics, Inc. 2022 Inducement P.


















